Join
Live feed
·
INSIDERFilingvia Quantisnow
Allarity Therapeutics Inc. logo

CEO Jensen Thomas was granted 396,734 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALLR (Allarity Therapeutics Inc.) and more on Quantisnow.

CEO Jensen Thomas was granted 396,734 shares (SEC Form 4) | Quantisnow